Cannabis Adverse Reactions in Canada: 6 Years of Safety Data
A new Health Canada analysis of six years of cannabis adverse reaction reports reveals patterns in who reports, what products are involved, and what symptoms arise—but the system's inherent limitations mean true incidence rates remain unknown.
Geriatric Medical Cannabis Clinic: Feasibility Data Review
Researchers at VCU describe a physician-led medical cannabis certification clinic integrated into geriatric primary care. Preliminary data from 144 visits reveals a medically complex, high-polypharmacy population with frequent drug-cannabis…
Cannabis Drug Interactions in Chronic Disease: Thai Study Findings
A new mixed-methods study from southern Thailand finds widespread cannabis use as a complementary medicine among chronic disease patients—and a striking gap: only one in three users knew cannabis could interact with their prescribed drugs.
Cannabis Before Eye Exams: Glaucoma Screening Risk Revealed
A cross-sectional survey of 134 ophthalmology patients found that nearly 1 in 6 had used cannabis within the past month, and 4.5% within 24 hours of IOP measurement — raising important questions about glaucoma diagnostic accuracy in the era of cannabis…
FDA Botanical Drug Pathway for Cannabis: Why Zero Approvals Exist
Researchers from BRC Therapeutics explain the scientific, regulatory, and logistical obstacles standing between cannabis and FDA drug approval—and why collaboration across sectors is essential to close the evidence gap.
Canada 2015 Cannabis Survey: Medical vs Recreational Users Compared
Before cannabis legalization, roughly 1 in 8 Canadians reported past-year use. A Statistics Canada analysis reveals who those users were, how often they used, and what distinguished those reporting medical use from purely recreational users—with…
Selonabant Blocks THC High in Phase II Trial | Evidence Watch
Sponsored Phase II trial shows selonabant sharply cuts subjective cannabis intoxication effects in healthy volunteers—but the coadministration design, small Part B sample, and absence of a post-intoxication rescue paradigm leave major questions for…
Multi-Modal Cannabis Use Among Young Adults: BRFSS 2022-2023
More than half of cannabis-using young adults in a 23-state U.S. survey used two or more consumption methods. New findings from the 2022–2023 BRFSS identify who is most at risk and how state policy shapes use patterns—but causal conclusions are not yet…
Smokable Cannabis Legalization Florida: THC Dispensing Up 42%
When Florida legalized smokable medical cannabis in 2019, dispensed THC per certified patient jumped by roughly 42% immediately and kept rising—but the study measures what was dispensed, not consumed, and lacks a control group.
Medical Cannabis and Healthcare Professionals: Beyond Knowledge Gaps
A scoping review of 34 studies finds that the medical cannabis literature fixates on knowledge gaps while largely ignoring professional identity, social norms, and environmental barriers that may be equally influential in shaping clinical behaviour.